Transmitted drug resistance to NRTIs and risk of virological failure in naïve patients treated with integrase inhibitors

Medicine and Dentistry

• Reverse-Transcriptase Inhibitor 100%
• Drug Resistance 80%
• Patient 80%
• Resistance Mutation 60%
• Raltegravir 60%
• Dolutegravir 60%
• Human Immunodeficiency Virus 40%
• RNA 40%
• Hazard Ratio 40%
• Integrase 40%
• Spine 40%
• Follow up 20%
• Combination Therapy 20%
• Age 20%
• Thymidine 20%
• Antiretroviral Therapy 20%
• Lamivudine 20%
• Tenofovir 20%
• Abacavir 20%
• Integrase Inhibitor 20%
• Emtricitabine 20%
• Analysis 20%
• Man 20%

Pharmacology, Toxicology and Pharmaceutical Science

• RNA Directed DNA Polymerase Inhibitor 100%
• Drug Resistance 80%
• Raltegravir 60%
• Dolutegravir 60%
• HIV 40%
• RNA 40%
• Integrase 40%
• Thymidine 20%
• Lamivudine 20%
• Integrase Inhibitor 20%
• Tenofovir 20%
• Emtricitabine 20%
• Abacavir 20%

Immunology and Microbiology

• Mutation 80%
• Drug Resistance 80%
• Reverse Transcriptase 60%
• Integrase 60%
• Human Immunodeficiency Virus 40%
• Viral Load 40%
• Age 20%
• CD4 Lymphocyte Count 20%
• Tenofovir 20%